PMEF
NVRO

Point72 Middle East FZE’s NEVRO CORP. NVRO Stock Holding History

Point72 Middle East FZE’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,274
Closed -$92K – 1406
2023
Q4 		$92K Buy
+4,274
New +$76.3K ﹤0.01% 1205
2023
Q1 		– Sell
-4,708
Closed -$186K – 2305
2022
Q4 		$186K Buy
+4,708
New +$196K 0.01% 1074

Other funds holding NVRO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Point72 Middle East FZE's NVRO Position: Q1 2024 in Review

Point72 Middle East FZE sold out of NEVRO CORP. (NVRO) in Q1 2024, closing a stake of 4,274 shares — an estimated $92K sold.

Point72 Middle East FZE first reported a position in NVRO in Q4 2022 and held it in 2 quarters. The position peaked at $186K in Q4 2022. 153 funds tracked by Wall St. Rank hold NVRO as of Q1 2024.

  • Point72 Middle East FZE reported no remaining NEVRO CORP. position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 4,274 NEVRO CORP. shares in Q1 2024, an estimated $92K.
  • Point72 Middle East FZE first reported a position in NEVRO CORP. in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's NEVRO CORP. position peaked at $186K in Q4 2022.
  • 153 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.